These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 11412388

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [The effect of serum TGFb1 of patients with chronic hepatitis B in liver fibrosis formation].
    Liu F, Li B, Nan Y.
    Zhonghua Gan Zang Bing Za Zhi; 1999 Dec; 7(4):196-8. PubMed ID: 10715784
    [Abstract] [Full Text] [Related]

  • 23. ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis.
    Zheng M, Cai WM, Weng HL, Liu RH.
    World J Gastroenterol; 2002 Dec; 8(6):1073-6. PubMed ID: 12439928
    [Abstract] [Full Text] [Related]

  • 24. [Therapeutic effects of octreotide on hepatofibrosis-induced with carbon tetrachloride in rats].
    Wang ZR, Li DG, Chen XM, Huang X, Wei HS, Wang YQ, Xu QF, Lu HM.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):408-11. PubMed ID: 12890342
    [Abstract] [Full Text] [Related]

  • 25. [Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model].
    Kim MY, Baik SK, Jang YO, Suk KT, Kim JW, Kim HS, Cho MY, Choi SJ, Um SH, Han KH.
    Korean J Hepatol; 2008 Jun; 14(2):159-67. PubMed ID: 18617763
    [Abstract] [Full Text] [Related]

  • 26. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis.
    Flisiak R, Maxwell P, Prokopowicz D, Timms PM, Panasiuk A.
    Hepatogastroenterology; 2002 Jun; 49(47):1369-72. PubMed ID: 12239944
    [Abstract] [Full Text] [Related]

  • 27. [Clinical and pathological study on liver fibrosis in viral hepatitis].
    Xin S, Mao Y, Wang L, Li Y, Li L, Yu H, Zhao M, Zhang S, Wang S, Wang X, Chen L, Zhou X, Zhou Y, Zou Z, Tang S, Huangpu Y, Zhang L.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):240-3. PubMed ID: 15617338
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
    Lieber CS, Weiss DG, Paronetto F, Veterans Affairs Cooperative Study 391 Group.
    Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
    [Abstract] [Full Text] [Related]

  • 30. Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver.
    Tsukamoto T, Yamamoto T, Ikebe T, Takemura S, Shuto T, Kubo S, Hirohashi K, Kinoshita H.
    Hepatogastroenterology; 2004 Jun; 51(57):777-80. PubMed ID: 15143915
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [The relationship between hepatic expression, serum level of TGFbeta1 and the hepatic fibrosis in patients with viral hepatitis].
    Li BS, Yan WZ, Liu JX, Zhen Z, Kong L, Liu F.
    Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):271-3. PubMed ID: 15161500
    [Abstract] [Full Text] [Related]

  • 33. Serum hyaluronic acid as a marker of hepatic fibrosis.
    Khan JA, Khan FA, Dilawar M, Ijaz A, Khan NA, Mehmood T.
    J Coll Physicians Surg Pak; 2007 Jun; 17(6):323-6. PubMed ID: 17623578
    [Abstract] [Full Text] [Related]

  • 34. [Correlation between HBsAg, HCV expression in cancerous and pericancer tissues of hepatocellular carcinoma and liver fibrosis markers in serum].
    Xin YN, Xuan SY, Shi GJ, Chen H, Sun Y, Zhang J.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):513-5. PubMed ID: 16042887
    [Abstract] [Full Text] [Related]

  • 35. [Changes in transforming growth factor beta 1 mRNA and its clinical value in patients with schistosomal liver fibrosis].
    Chen F, Cai W, Chen Z, Liu R.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999 Jul; 17(3):140-2. PubMed ID: 12563829
    [Abstract] [Full Text] [Related]

  • 36. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
    Yilmaz S, Bayan K, Tüzün Y, Dursun M, Kaplan A, Ozmen S, Canoruç F, Akkuş Z.
    Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
    [Abstract] [Full Text] [Related]

  • 37. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS, Wang BE, Wang TL, Jia JD, Qian LX.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
    [Abstract] [Full Text] [Related]

  • 38. [Diagnostic significance of type IV collagen and hyaluronic acid in the serum of patients with chronic hepatitis C for staging hepatic fibrosis].
    Iushchuk ND, Znoĭko OO, Safiullina NKh, Dudina KR, Kelli EI, Klimova EA, Kashirin VI, Braginskiĭ DM, Kushlinskiĭ NE, Liubimova NV, Vasilev AIu, Penkina TV, Danilin AG.
    Ter Arkh; 2005 Aug; 77(4):50-5. PubMed ID: 15938533
    [Abstract] [Full Text] [Related]

  • 39. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
    Trocme C, Leroy V, Sturm N, Hilleret MN, Bottari S, Morel F, Zarski JP.
    J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
    [Abstract] [Full Text] [Related]

  • 40. [Determination and significance of serum markers for fibrosis in patients with chronic hepatitis].
    Cai W, Zheng M, Weng H, Liu R.
    Zhonghua Nei Ke Za Zhi; 2001 Jul; 40(7):448-51. PubMed ID: 11798612
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.